This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX6HN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a medical product, with a ceiling value of $1,461.18. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD7WY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,045.32 firm fixed-price delivery order is for the medication Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of April 29, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEHF2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,251.90, for the supply of Trelegy Ellipta 100-62.5-25 60S medication. The contract is not designated as a set-aside and has an ultimate completion date of April 11, 2025. AmerisourceBergen Drug...
The federal contract award, with ID SPE2DB20D2104|SPE2DB25FMBWQ, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.12 firm fixed-price delivery order is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has an ultimate completion date of November 14, 2024 and is not designated as a set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,503.80, is for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. It is a firm-fixed-price delivery order contract with a completion date of March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8MH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,244.65 Firm Fixed Price Delivery Order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a period of performance through March 27, 2025 and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract has a ceiling value of $4,582.58 and runs through May 28, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,245.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a period of performance through April 17, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 100-62.5-25 60s medication. The contract has a ceiling value of $8,806.76 and a period of performance through March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,649.78, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...